Skip to main content
. Author manuscript; available in PMC: 2016 Feb 4.
Published in final edited form as: Cancer Immunol Immunother. 2015 Mar 21;64(6):737–744. doi: 10.1007/s00262-015-1680-x

Fig. 4.

Fig. 4

Summary of CTL assays for AML elimination by autologous AML-reactive T cells generated under various conditions (T + L + R, T + L, T + R, L + R, or L vs medium, p < 0.01; T + R vs T or R, p < 0.01 for both; T + L + R vs T or R, p < 0.01 for both). The data shown represent the combined data from studies of nine AML patients